Smithfield Trust’s CervoMed CRVO Stock Holding History

Smithfield Trust’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2	Closed	–	–	942
2018 Q4	$0	Hold	2	–	–	﹤0.01%	947
2018 Q3	$1K	Hold	2	–	–	﹤0.01%	983
2018 Q2	$1K	Hold	2	–	–	﹤0.01%	1001
2018 Q1	$1K	Hold	2	–	–	﹤0.01%	1021
2017 Q4	$2K	Hold	2	–	–	﹤0.01%	1024
2017 Q3	$3K	Buy	+2	New	+$4.14K	﹤0.01%	782

Other funds holding CRVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Smithfield Trust's CRVO Position: Q1 2019 in Review

Smithfield Trust sold out of CervoMed (CRVO) in Q1 2019, closing a stake of 2 shares.

Smithfield Trust first reported a position in CRVO in Q3 2017 and held it in 6 quarters. The position peaked at $3K in Q3 2017. 9 funds tracked by Wall St. Rank hold CRVO as of Q1 2019.

Smithfield Trust reported no remaining CervoMed position as of Q1 2019 after selling out during the quarter.
Smithfield Trust sold 2 CervoMed shares in Q1 2019.
Smithfield Trust first reported a position in CervoMed in Q3 2017 and held it in 6 quarters.
Smithfield Trust's CervoMed position peaked at $3K in Q3 2017.
9 funds tracked by Wall St. Rank held CervoMed as of Q1 2019.

Based on Smithfield Trust's 13F filing for Q1 2019, filed 30 Apr 2019.